These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 35281516)
21. HNF4G accelerates glioma progression by facilitating NRP1 transcription. Che H; Zheng Q; Liao Z; Zhang L Oncol Lett; 2023 Mar; 25(3):102. PubMed ID: 36817051 [TBL] [Abstract][Full Text] [Related]
22. Neuropilin-1 contributes to esophageal squamous cancer progression via promoting P65-dependent cell proliferation. Shi F; Shang L; Yang LY; Jiang YY; Wang XM; Hao JJ; Zhang Y; Huang DK; Cai Y; Xu X; Zhan QM; Jia XM; Cao Y; Wang MR Oncogene; 2018 Feb; 37(7):935-943. PubMed ID: 29059172 [TBL] [Abstract][Full Text] [Related]
23. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways. Yang L; Hu Y; Zhou G; Chen Q; Song Z Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32677672 [TBL] [Abstract][Full Text] [Related]
24. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system. Jin M; Shi C; Li T; Wu Y; Hu C; Huang G Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676 [TBL] [Abstract][Full Text] [Related]
25. Plumbagin induces G2/M arrest, apoptosis, and autophagy via p38 MAPK- and PI3K/Akt/mTOR-mediated pathways in human tongue squamous cell carcinoma cells. Pan ST; Qin Y; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1601-26. PubMed ID: 25834400 [TBL] [Abstract][Full Text] [Related]
26. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways. Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152 [TBL] [Abstract][Full Text] [Related]
27. RCE‑4, a potential anti‑cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells. Xiang W; Zhang RJ; Jin GL; Tian L; Cheng F; Wang JZ; Xing XF; Xi W; Tang SJ; Chen JF Int J Mol Med; 2020 Jan; 45(1):245-254. PubMed ID: 31746346 [TBL] [Abstract][Full Text] [Related]
28. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells. Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171 [TBL] [Abstract][Full Text] [Related]
29. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. Nicholl SM; Roztocil E; Davies MG J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933 [TBL] [Abstract][Full Text] [Related]
30. Effects of MLL5 and HOXA regulated by NRP1 on radioresistance in A549. Shao L; Zhang Y; Gong X; Dong Z; Wei W; Sun H; Sun R; Cong L; Cong X; Jin S Oncol Lett; 2021 May; 21(5):403. PubMed ID: 33777226 [TBL] [Abstract][Full Text] [Related]
31. VEGF-A/NRP1 stimulates GIPC1 and Syx complex formation to promote RhoA activation and proliferation in skin cancer cells. Yoshida A; Shimizu A; Asano H; Kadonosono T; Kondoh SK; Geretti E; Mammoto A; Klagsbrun M; Seo MK Biol Open; 2015 Jul; 4(9):1063-76. PubMed ID: 26209534 [TBL] [Abstract][Full Text] [Related]
32. Zeylenone, a naturally occurring cyclohexene oxide, inhibits proliferation and induces apoptosis in cervical carcinoma cells via PI3K/AKT/mTOR and MAPK/ERK pathways. Zhang L; Huo X; Liao Y; Yang F; Gao L; Cao L Sci Rep; 2017 May; 7(1):1669. PubMed ID: 28490807 [TBL] [Abstract][Full Text] [Related]
33. New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies. Zhao L; Chen H; Lu L; Wang L; Zhang X; Guo X J Drug Target; 2021 Feb; 29(2):155-167. PubMed ID: 32838575 [TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor-induced matrix metalloproteinase-1 expression is negatively regulated by p38 MAPK in human skin fibroblasts. Park CH; Chung JH J Dermatol Sci; 2011 Nov; 64(2):134-41. PubMed ID: 21872446 [TBL] [Abstract][Full Text] [Related]
35. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
36. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways. Shin DY; Kim GY; Hwang HJ; Kim WJ; Choi YH Environ Toxicol Pharmacol; 2014 Jan; 37(1):74-83. PubMed ID: 24309133 [TBL] [Abstract][Full Text] [Related]
37. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2. He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784 [TBL] [Abstract][Full Text] [Related]
38. Neuropilin-1-dependent regulation of EGF-receptor signaling. Rizzolio S; Rabinowicz N; Rainero E; Lanzetti L; Serini G; Norman J; Neufeld G; Tamagnone L Cancer Res; 2012 Nov; 72(22):5801-11. PubMed ID: 22986738 [TBL] [Abstract][Full Text] [Related]
39. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma. Peng X; Liu Y; Zhu S; Peng X; Li H; Jiao W; Lin P; Zhang Z; Qiu Y; Jin M; Wang R; Kong D J Cancer Res Clin Oncol; 2019 Dec; 145(12):2921-2936. PubMed ID: 31620898 [TBL] [Abstract][Full Text] [Related]
40. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]